Literature DB >> 17911604

Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells.

Ruobing Li1, Nicolas Perez, Subha Karumuthil-Melethil, Bellur S Prabhakar, Mark J Holterman, Chenthamarakshan Vasu.   

Abstract

CTLA-4 is a critical negative regulator of T cell response and is instrumental in maintaining immunological tolerance. In this article, we report that enhanced selective engagement of CTLA-4 on T cells by Ag-presenting dendritic cells resulted in the induction of Ag-specific CD4(+)CD25(+)Foxp3(+) and CD4(+)CD25(-)TGF-beta1(+) adaptive Tregs. These cells were CD62L(low) and hyporesponsive to stimulation with cognate Ag but demonstrated a superior ability to suppress Ag-specific effector T cell response compared with their CD62L(high) counterparts. Importantly, treatment of mice with autoimmune thyroiditis using mouse thyroglobulin (mTg)-pulsed anti-CTLA-4 agonistic Ab-coated DCs, which results in a dominant engagement of CTLA-4 upon self-Ag presentation, not only suppressed thyroiditis but also prevented reemergence of the disease upon rechallenge with mTg. Further, the disease suppression was associated with significantly reduced mTg-specific T cell and Ab responses. Collectively, our results showed an important role for selective CTLA-4 signaling in the induction of adaptive Tregs and suggested that approaches that allow dominant CTLA-4 engagement concomitant with Ag-specific TCR ligation can be used for targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17911604     DOI: 10.4049/jimmunol.179.8.5191

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  HIV-specific TGF-beta-positive CD4+ T cells do not express regulatory surface markers and are regulated by CTLA-4.

Authors:  Mohamed Elrefaei; Candace M Burke; Chris A R Baker; Norman G Jones; Stephanie Bousheri; David R Bangsberg; Huyen Cao
Journal:  AIDS Res Hum Retroviruses       Date:  2010-03       Impact factor: 2.205

2.  CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.

Authors:  Hyun-Bae Jie; Patrick J Schuler; Steve C Lee; Raghvendra M Srivastava; Athanassios Argiris; Soldano Ferrone; Theresa L Whiteside; Robert L Ferris
Journal:  Cancer Res       Date:  2015-04-01       Impact factor: 12.701

3.  Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation.

Authors:  Nicolas Perez; Subha Karumuthil-Melethil; Ruobing Li; Bellur S Prabhakar; Mark J Holterman; Chenthamarakshan Vasu
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

4.  Aberrant expression of costimulatory molecules in splenocytes of the mevalonate kinase-deficient mouse model of human hyper-IgD syndrome (HIDS).

Authors:  Elizabeth J Hager; Jon D Piganelli; Hubert M Tse; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2011-05-24       Impact factor: 4.982

5.  Dendritic cell-directed CTLA-4 engagement during pancreatic beta cell antigen presentation delays type 1 diabetes.

Authors:  Subha Karumuthil-Melethil; Nicolas Perez; Ruobing Li; Bellur S Prabhakar; Mark J Holterman; Chenthamarakshan Vasu
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

6.  Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity.

Authors:  Rizwanul Haque; Fengyang Lei; Xiaofang Xiong; Yanqing Bian; Baohua Zhao; Yuzhang Wu; Jianxun Song
Journal:  J Immunol       Date:  2012-06-25       Impact factor: 5.422

Review 7.  The dual role of the X-linked FoxP3 gene in human cancers.

Authors:  Margaret Redpath; Bin Xu; Leon C van Kempen; Alan Spatz
Journal:  Mol Oncol       Date:  2011-03-30       Impact factor: 6.603

8.  Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner.

Authors:  T Zhang; S Fresnay; E Welty; N Sangrampurkar; E Rybak; H Zhou; X-F Cheng; Q Feng; C Avon; A Laaris; M Whitters; A M Nagelin; R M O'Hara; A M Azimzadeh
Journal:  Am J Transplant       Date:  2011-07-12       Impact factor: 8.086

9.  Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection.

Authors:  Koyo Higashitani; Tatsuya Kanto; Shoko Kuroda; Sachiyo Yoshio; Tokuhiro Matsubara; Naruyasu Kakita; Tsugiko Oze; Masanori Miyazaki; Mitsuru Sakakibara; Naoki Hiramatsu; Eiji Mita; Yasuharu Imai; Akinori Kasahara; Alato Okuno; Osamu Takikawa; Norio Hayashi; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2012-09-14       Impact factor: 7.527

10.  A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of type 1 diabetes in NOD mice.

Authors:  Palash Bhattacharya; Jilao Fan; Christine Haddad; Abdul Essani; Anupama Gopisetty; Hatem A Elshabrawy; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Clin Immunol       Date:  2014-05-02       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.